Agency Information Collection Activities: Proposed Collection: Comment Request, 66787-66788 [E6-19377]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 221 / Thursday, November 16, 2006 / Notices
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: November 9, 2006.
Robert Sargis,
Report Clearance Officer.
[FR Doc. 06–9223 Filed 11–15–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Title: Public Education Study on
Public Knowledge of Abstinence and
Abstinence Education.
OMB No.: New Collection.
Description: In support of the goal to
prevent unwed childbearing, pregnancy,
and sexually transmitted diseases,
Congress has recently authorized
funding increases to support abstinence
education.
66787
To learn more about the public’s
views, the Administration for Children
and Families (ACF) will conduct a
public opinion survey of a nationally
representative sample of adolescents
(age 12 to 18) and their parents to
examine current attitudes on abstinence
and knowledge of abstinence education.
The survey data will be used to inform
current and future public education
campaigns. In addition, the information
gathered will assist ACF with grant
administration and technical assistance
activities. The survey will ask parents
(one parent per adolescent) and
adolescents about their views and
attitudes about abstinence until
marriage, awareness of abstinence
education, and views and attitudes
about abstinence education. Each parent
and adolescent interview will take
approximately 20 minutes to complete.
Respondents: A nationally
representative sample of adolescents
will be selected through a random-digitdial sample of households with landline
telephones.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total
burden hours
Telephone interview .........................................................................................
1 2,000
1
0.33
660
pwalker on PROD1PC61 with NOTICES
1 1,000
adolescent/parent pairs.
Total annual burden estimates: 660.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
VerDate Aug<31>2005
20:27 Nov 15, 2006
Jkt 211001
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: November 8, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–9224 Filed 11–15–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, call the
HRSA Reports Clearance Officer on
(301) 443–1129.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
E:\FR\FM\16NON1.SGM
16NON1
66788
Federal Register / Vol. 71, No. 221 / Thursday, November 16, 2006 / Notices
Proposed Project: Health Resources and
Services Administration Core Clinical
Measures Implementation Feasibility
Study
In response to the Health and Human
Service’s Department-wide objectives
and HRSA’s strategic goals, a set of core
clinical performance measures have
been established. These measures will
assist in the evaluation of HRSA
program performance in defined clinical
areas to facilitate quality improvement
activities for HRSA and its grantees. The
purpose of the proposed voluntary
feasibility study is to learn from HRSA’s
health service delivery grantees, which
have different reporting capacities,
about their abilities to report national
standardized measures. More
specifically, the study will help HRSA
to understand: (1) The factors involved
in the HRSA grantee decision making
processes around measure selection/
choice; (2) Grantees’ data collection
capacity including tools, processes and
infrastructure; (3) Level of grantee effort
involved in measure reporting; and (4)
How the performance process will
impact the grantees’ quality
improvement efforts. Overall the
feasibility study will allow HRSA to
query its grantees related to the newly
Responses
per
respondent
Number of
respondents
introduced core clinical performance
measure set.
The feasibility study includes the
actual data collection of the proposed
clinical measures along with a report
form to assess burden, data collection
and reporting capacity, and technical
assistance needs. Additionally, the
study will provide HRSA with the
opportunity to refine instructions and
performance measure definitions
accordingly in preparation for the actual
implementation of the clinical
measures.
The estimated annualized response
burden is as follows:
Total
responses
Hours per
response
Total hour
burden
Clinical Measures ...............................................................
Report Form .......................................................................
50
50
1
1
50
50
40
1.5
2,000
75
Total ............................................................................
50
........................
50
..........................
2075
Send comments to Susan G. Queen,
Ph.D., HRSA Reports Clearance Officer,
Room 10–33, Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
Written comments should be received
within 60 days of this notice.
Dated: November 8, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–19377 Filed 11–15–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
pwalker on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
VerDate Aug<31>2005
20:27 Nov 15, 2006
Jkt 211001
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Second Generation Nitric OxideReleasing Non-Steroidal AntiInflammatory Drugs Possessing a
Diazeniumdiolate Group (NONO–
NSAIDs)
Description of Technology: Nonsteroidal anti-inflammatory drugs
(NSAIDs) are one of the most useful
clinical therapies for the treatment of
pain, fever and inflammation. It is
estimated that more than 30 million
people take NSAIDs every day.
However, the major mechanism by
which NSAIDs exert their antiinflammatory activity is also responsible
for the gastrointestinal, renal and
hepatic side effects observed in patients
undergoing long-term treatment of
chronic conditions. The most common
side effects associated with NSAID
administration are gastroduodenal
erosions and ulcerations affecting
around 15% of chronic NSAID users.
While many of these clinical
manifestations are mild, they may
develop into serious events such as
bleeding, perforation, obstruction, and
sudden death. Therefore, the gastric
irritant effect of NSAIDs (particularly
aspirin) can be a deterrent to its longterm use for the prophylactic prevention
of adverse cardiovascular events such as
stroke and myocardial infarction, or as
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
a safe chemopreventive agent to avoid
the recurrence of colorectal cancer
(CRC).
One of the main strategies that have
emerged to improve the safety profile of
NSAIDs is the linkage of a nitric oxide
(NO)-releasing moiety to the structure of
classical NSAIDs (NO–NSAIDs).
However, all NO-releasing NSAIDs
published so far have a nitrooxyalkyl
group as the NO-releasing group. An
important drawback to this design is the
fact that production of NO (only one
equivalent) from organic nitrate esters
requires a metabolic three-electron
reduction in vivo, and this activation
decreases in efficiency on continued use
of the drugs, contributing to ‘‘nitrate
tolerance’’.
This invention describes the design,
synthesis and biological evaluation of
novel NO-releasing non-steroidal antiinflammatory prodrugs (NONO–
NSAIDs) possessing a N-diazen-1-ium1,2-diolate (NONOate), which offers
additional advantages compared with
organic nitrate-based NO–NSAIDs:
(a) Simultaneous release of the
corresponding NSAID and NO.
(b) Production of two equivalents of
NO (twice as much) by a first-order rate.
(c) Metabolic activation (hydrolysis)
mediated by non-specific esterases,
which unlike redox metabolism, is not
expected to produce tolerance upon
long-term treatment.
Applications: This invention provides
a group of anti-inflammatory, analgesic,
and gastrointestinal safe prodrugs,
which are expected to be a suitable
alternative for the prophylactic
prevention of adverse cardiovascular
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 71, Number 221 (Thursday, November 16, 2006)]
[Notices]
[Pages 66787-66788]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19377]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Comment Request
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, call the HRSA Reports Clearance
Officer on (301) 443-1129.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
[[Page 66788]]
Proposed Project: Health Resources and Services Administration Core
Clinical Measures Implementation Feasibility Study
In response to the Health and Human Service's Department-wide
objectives and HRSA's strategic goals, a set of core clinical
performance measures have been established. These measures will assist
in the evaluation of HRSA program performance in defined clinical areas
to facilitate quality improvement activities for HRSA and its grantees.
The purpose of the proposed voluntary feasibility study is to learn
from HRSA's health service delivery grantees, which have different
reporting capacities, about their abilities to report national
standardized measures. More specifically, the study will help HRSA to
understand: (1) The factors involved in the HRSA grantee decision
making processes around measure selection/choice; (2) Grantees' data
collection capacity including tools, processes and infrastructure; (3)
Level of grantee effort involved in measure reporting; and (4) How the
performance process will impact the grantees' quality improvement
efforts. Overall the feasibility study will allow HRSA to query its
grantees related to the newly introduced core clinical performance
measure set.
The feasibility study includes the actual data collection of the
proposed clinical measures along with a report form to assess burden,
data collection and reporting capacity, and technical assistance needs.
Additionally, the study will provide HRSA with the opportunity to
refine instructions and performance measure definitions accordingly in
preparation for the actual implementation of the clinical measures.
The estimated annualized response burden is as follows:
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total hour
respondents respondent responses response burden
----------------------------------------------------------------------------------------------------------------
Clinical Measures.............. 50 1 50 40 2,000
Report Form.................... 50 1 50 1.5 75
--------------------------------------------------------------------------------
Total...................... 50 .............. 50 ............... 2075
----------------------------------------------------------------------------------------------------------------
Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance
Officer, Room 10-33, Parklawn Building, 5600 Fishers Lane, Rockville,
MD 20857. Written comments should be received within 60 days of this
notice.
Dated: November 8, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-19377 Filed 11-15-06; 8:45 am]
BILLING CODE 4165-15-P
